{
    "xml": "<topic id=\"PHP95856\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/femoston-conti-1-mg5\" basename=\"femoston-conti-1-mg5\" title=\"Femoston-conti 1&#8239;mg/5\">\n<title>Femoston<tm tmtype=\"reg\"/>-conti 1&#8239;mg/5</title>\n<topic id=\"PHP96067\" outputclass=\"indicationsAndDose\" rev=\"1.16\" parent=\"/clinical-medicinal-product-information/femoston-conti-1-mg5\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>\n<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP95856",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/femoston-conti-1-mg5",
    "basename": "femoston-conti-1-mg5",
    "title": "Femoston-conti 1â€¯mg/5",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously",
                        "html": "Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"
                    },
                    {
                        "textContent": "Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously",
                        "html": "Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.",
                        "html": "<p>1&#8239;tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.</p>"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}